CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CALC CALCIMEDICA

Not Yet Opened 11-21 16:00:00 EST

3.45

+0.00

0.00%

High3.46	Low3.40	Vol18.34K
Open3.45	D1 Closing3.45	Amplitude1.74%
Mkt Cap46.47M	Tradable Cap22.78M	Total Shares13.47M
T/O63.07K	T/O Rate0.28%	Tradable Shares6.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":3.45,"timestamp":1732222800000,"preClose":3.45,"halted":0,"volume":18341,"delay":0,"floatShares":6603300,"shares":13470156,"eps":-1.43929,"marketStatus":"Not Yet Opened","change":0,"latestTime":"11-21 16:00:00 EST","open":3.45,"high":3.46,"low":3.4,"amount":63074.2836,"amplitude":0.017391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.43929,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732266000000},"marketStatusCode":0,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":3.45,"volumeRatio":0.518418},"requestUrl":"/m/hq/s/CALC/wiki","defaultTab":"wiki","newsList":[{"id":"2485175596","title":"CalciMedica Announces Presentations at Upcoming Medical Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2485175596","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485175596?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:05","pubTimestamp":1732136700,"startTime":"0","endTime":"0","summary":"Prof. Robert Sutton todeliver plenary presentation on Phase 2b CARPO trial of Auxora in Acute Pancreatitis at American Pancreatic Association  2024 Annual Meeting. Poster presentation on Phase 2b CARPO trial at Emergencies in Medicine  2024 Meeting. LA JOLLA, Calif., Nov. 20, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for plenary presentation at the American Pancreatic Association  2024 Annual Meeting being held December 9-10 in Maui, HI, and the acceptance of an abstract for poster presentation at the Emergencies in Medicine  2024 Meeting being held December 8-13 in Maui, HI.Presentation Title: Auxora Decreases the Development of Severe Organ Failure in Patients with Acute Pancreatitis and SIRS. Presenter:Prof. Robert Sutton, B.A. , M.B., B.S., D.P","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-210500876.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-announces-presentations-upcoming-medical-210500876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","CALC","BK4213","EIM","BK4585","BK4588","BK4006","APA","AP"],"gpt_icon":0},{"id":"2483382292","title":"CalciMedica Price Target Maintained With a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483382292?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:45","pubTimestamp":1731581100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 05:45 ET (10:45 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483318838","title":"CalciMedica’s Financial Strength and Clinical Advancements Lead to Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2483318838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483318838?lang=en_us&edition=fundamental","pubTime":"2024-11-13 23:35","pubTimestamp":1731512115,"startTime":"0","endTime":"0","summary":"Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on CalciMedica (CALC – Research Report), retaining the price target of $16.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/calcimedicas-financial-strength-and-clinical-advancements-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/calcimedicas-financial-strength-and-clinical-advancements-lead-to-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2483288636","title":"CalciMedica Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483288636","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483288636?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:15","pubTimestamp":1731507355,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc    reported a quarterly adjusted loss of 50 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -82 cents.  T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483325000","title":"BRIEF-Calcimedica Reports Third Quarter 2024 Financial Results And Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483325000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483325000?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:23","pubTimestamp":1731504202,"startTime":"0","endTime":"0","summary":"Nov 13  - CalciMedica Inc   :   * CALCIMEDICA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CLINICAL & CORPORATE UPDATES   * CALCIMEDICA INC: CASH POSITION IS EXPECTED TO FUND CURRENT OPERATIONS INTO FIRST HALF OF 2026Source text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2483538009","title":"CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538009","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483538009?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:16","pubTimestamp":1731500183,"startTime":"0","endTime":"0","summary":"CalciMedica (NASDAQ:CALC) reported quarterly losses of $(0.50) per share which met the analyst consensus estimate.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41935435/calcimedica-q3-2024-gaap-eps-0-50-inline-proforma-cash-cash-equivalents-and-short-term-investments-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CalciMedica Q3 2024 GAAP EPS $(0.50), Inline, Proforma Cash, Cash Equivalents And Short-term Investments Of Approximately $23.7M, Which Is Expected To Fund Current Operations Into The First Half Of 2026","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2483005759","title":"CalciMedica Inc: Cash Position Is Expected to Fund Current Operations Into First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2483005759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483005759?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUAB9HBV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2483005119","title":"CalciMedica Q3 Basic EPS USD -0.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2483005119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483005119?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nPLXC13565:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2483900948","title":"CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483900948","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483900948?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:00","pubTimestamp":1731499200,"startTime":"0","endTime":"0","summary":"Additional positive data, including a win ratio analysis, announced from CARPO Phase 2b trial of Auxora in acute pancreatitis ; Company expects to be in a position to initiate Phase 3 program in 2025. Enrollment ongoing in Phase 2 KOURAGE trial in acute kidney injury  and in Phase 2 portion of CRSPA trial in asparaginase-induced pancreatic toxicity ; data from both trials expected in 2025. Following a public offering in October, the Company's cash position is expected to fund current operations into the first half of 2026. LA JOLLA, Calif., Nov. 13, 2024 /PRNewswire/ -- CalciMedica Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today reported financial results for the third quarter ended September 30, 2024 and provided clinical and corporate updates.Auxora demonstrated a statistically significant 100% relative risk reduction  in n","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-reports-third-quarter-2024-120000483.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-reports-third-quarter-2024-120000483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","AP","BK4007","BK4006"],"gpt_icon":0},{"id":"2482821781","title":"PK AirFinance Arranges and Funds Scaled Portfolio Facility for CALC’s Sidecar Platform (CAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482821781","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482821781?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:00","pubTimestamp":1731330000,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov. 11, 2024  -- PK AirFinance , a leading aviation lending platform and affiliate of Apollo , today announced the arrangement and funding of a $550 million loan facility with China Aircraft Leasing Group ’s sidecar platform – China Aircraft Global . The portfolio is secured by 21 narrowbody and 2 widebody aircraft. The collateral pool is diversified among 15 different airline operators located across the globe. PK is acting as sole lender, admin agent and security trustee on the secured loan facility.Gary Rothschild, CEO of PK AirFinance, commented, “PK is pleased to support CALC on this important transaction, which we believe demonstrates PK’s ability to structure and deliver scaled, fully underwritten financing solutions with speed of execution as the sole lender. We continue to see increasing demand for these type of bespoke, large-scale financing solutions, which we can tailor to customers’ specific needs and serve as a more flexible alternative to public markets.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pk-airfinance-arranges-funds-scaled-130000843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4585","CAG","LU1571399168.USD","BK4588","GRO","LU1668664300.SGD","IE00B19Z3581.USD","LU0006061336.USD","BK4007","LU0106831901.USD","IE00B775SV38.USD","BK4135","LU1323610961.USD","IE00B19Z3B42.SGD","BK4212","BK4524","APO","PK","BK4184","CALC","BK4218","IE0002270589.USD","IE00B3S45H60.SGD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2481632902","title":"CalciMedica name Stephen Bardin as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481632902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481632902?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:16","pubTimestamp":1730985366,"startTime":"0","endTime":"0","summary":"CalciMedica (CALC) announced the appointment of Stephen Bardin as CFO and the planned departure of Daniel Geffken, Interim CFO upon filing the comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-name-stephen-bardin-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-name-stephen-bardin-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481034919","title":"BRIEF-CalciMedica Strengthens Leadership Team With Appointment Of Stephen Bardin As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481034919","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481034919?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:17","pubTimestamp":1730981852,"startTime":"0","endTime":"0","summary":"Nov 7  - CalciMedica Inc   :   * CALCIMEDICA STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF STEPHEN BARDIN AS CHIEF FINANCIAL OFFICER   * CALCIMEDICA INC - APPOINTS STEPHEN BARDIN AS CFO   * CALCIMEDICA INC - DANIEL GEFFKEN TO DEPART AS INTERIM CFOSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TISI","BK4120","BK4007","CALC"],"gpt_icon":0},{"id":"2481908712","title":"CalciMedica Inc - Appoints Stephen Bardin as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481908712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481908712?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481790850","title":"CalciMedica Strengthens Leadership Team With Appointment of Stephen Bardin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481790850","media":"THOMSON REUTERS","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481790850?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481087549","title":"CalciMedica Inc - Daniel Geffken to Depart as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2481087549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481087549?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUABJRGZB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2481908022","title":"CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2481908022","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481908022?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Nov. 7, 2024 /PRNewswire/ --CalciMedica, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium  channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the appointment of Stephen Bardin as Chief Financial Officer and the planned departure of Daniel Geffken,Interim Chief Financial Officer upon filing the Company's third quarter financial statements. Mr. Bardin brings extensive capital raising, corporate development, and strategic finance expertise to CalciMedica, having most recently served as CFO of atai Life Sciences.\"CalciMedica has made impressive recent progress, delivering compelling clinical data for large and underserved patient populations,\" said Mr. Bardin. \"The CARPO Phase 2b data in patients with acute pancreatitis announced last month is promising and provides an optimistic readthrough to KOURAGE, CalciMedica's Phase 2 trial in acute kidney injury,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MeD0tk6AKrx2QxGxO5XuHA--~B/aD03ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/2555f332bbc6176084dcbe2b673b28ae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/calcimedica-strengthens-leadership-team-appointment-120000105.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calcimedica-strengthens-leadership-team-appointment-120000105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CALC","AP","TISI","BK4006","BK4007","BK4120"],"gpt_icon":0},{"id":"2481600749","title":"CalciMedica Inc    expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481600749","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481600749?lang=en_us&edition=fundamental","pubTime":"2024-11-06 22:28","pubTimestamp":1730903304,"startTime":"0","endTime":"0","summary":"* CalciMedica Inc     is expected to show no change in quarterly revenue when it reports  results on November 7 (estimated) for the period ending September 30 2024   *    * LSEG's mean analyst estimat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CalciMedica Inc    expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2480301044","title":"CalciMedica Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301044?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:11","pubTimestamp":1730722260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CALC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2024 07:11 ET (12:11 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2480306934","title":"CalciMedica’s Auxora Shows Promise in Acute Pancreatitis: Analyst Recommends Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2480306934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480306934?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:26","pubTimestamp":1730719569,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on CalciMedica (CALC – Research Report) today and set a price target of $16.00. Jo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/calcimedicas-auxora-shows-promise-in-acute-pancreatitis-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/calcimedicas-auxora-shows-promise-in-acute-pancreatitis-analyst-recommends-buy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2480930530","title":"CalciMedica price target lowered to $16 from $20 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2480930530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480930530?lang=en_us&edition=fundamental","pubTime":"2024-11-04 19:16","pubTimestamp":1730718970,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on CalciMedica (CALC) to $16 from $20 and keeps a Buy rating on the shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/calcimedica-price-target-lowered-to-16-from-20-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/calcimedica-price-target-lowered-to-16-from-20-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CALC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":-0.1439},{"period":"3month","weight":-0.1399},{"period":"6month","weight":-0.3365},{"period":"1year","weight":0.2105},{"period":"ytd","weight":0.1775}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.425181},{"month":2,"riseRate":0,"avgChangeRate":-0.241659},{"month":3,"riseRate":0,"avgChangeRate":-0.299918},{"month":4,"riseRate":0.25,"avgChangeRate":-0.031156},{"month":5,"riseRate":0.25,"avgChangeRate":-0.049488},{"month":6,"riseRate":0.5,"avgChangeRate":0.039232},{"month":7,"riseRate":0.25,"avgChangeRate":-0.073078},{"month":8,"riseRate":0.5,"avgChangeRate":-0.039536},{"month":9,"riseRate":0.5,"avgChangeRate":-0.043748},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02961},{"month":11,"riseRate":0.2,"avgChangeRate":0.04586},{"month":12,"riseRate":0.5,"avgChangeRate":-0.082044}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CALCIMEDICA(CALC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction